Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adeel A Butt, MD, MS
University of Pittsburgh
Study Chair - Kenneth E Sherman, MD, PhD
University of Cincinnati CRS
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Puerto Rico Aids Clinical Trials Unit Crs
San Juan, Puerto Rico
- Alabama Crs
Birmingham, Alabama, United States
- Ucla Care Center Crs
Los Angeles, California, United States
- University of Southern California Crs
Los Angeles, California, United States
- Stanford Aids Clinical Trials Unit Crs
Palo Alto, California, United States
- Ucsd Antiviral Research Center Crs
San Diego, California, United States
- Ucsf Hiv/aids Crs
San Francisco, California, United States
- Harbor-Ucla Crs
Torrance, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Denver Public Health Crs
Denver, Colorado, United States
- Georgetown University Crs (gu Crs)
Washington D.C., District of Columbia, United States
- the Ponce de Leon Center Crs
Atlanta, Georgia, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Rush University Crs
Chicago, Illinois, United States
- Ihv Baltimore Treatment Crs
Baltimore, Maryland, United States
- Johns Hopkins University Crs
Baltimore, Maryland, United States
- Bmc Actg Crs
Boston, Massachusetts, United States
- Brigham and Women'S Hospital Therapeutics Clinical Research Site (bwh Tcrs) Crs
Boston, Massachusetts, United States
- Massachusetts General Hospital Crs (mgh Crs)
Boston, Massachusetts, United States
- Henry Ford Hosp. Crs
Detroit, Michigan, United States
- Wayne State Univ. Crs
Detroit, Michigan, United States
- Washington University Therapeutics (wt) Crs
St Louis, Missouri, United States
- Cooper Univ. Hosp. Crs
Camden, New Jersey, United States
- New Jersey Medical School Clinical Research Center Crs
Newark, New Jersey, United States
- Columbia P&s Crs
New York, New York, United States
- Weill Cornell Chelsea Crs
New York, New York, United States
- Weill Cornell Uptown Crs
New York, New York, United States
- University of Rochester Adult Hiv Therapeutic Strategies Network Crs
Rochester, New York, United States
- Bronx-Lebanon Hosp. Ctr. Crs
The Bronx, New York, United States
- Chapel Hill Crs
Chapel Hill, North Carolina, United States
- Duke Univ. Med. Ctr. Adult Crs
Durham, North Carolina, United States
- Cincinnati Clinical Research Site
Cincinnati, Ohio, United States
- Case Clinical Research Site
Cleveland, Ohio, United States
- Metrohealth Crs
Cleveland, Ohio, United States
- Ohio State University Crs
Columbus, Ohio, United States
- Penn Therapeutics, Crs
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Crs
Pittsburgh, Pennsylvania, United States
- the Miriam Hospital Clinical Research Site (tmh Crs) Crs
Providence, Rhode Island, United States
- Vanderbilt Therapeutics (vt) Crs
Nashville, Tennessee, United States
- Trinity Health and Wellness Center Crs
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2012
- Primary completion
- 30 Apr 2015
- Completion
- 30 Apr 2015
- Last update posted
- 4 Nov 2021
- Registered enrollment
- 262
- Registry id
- NCT01482767
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.